Physician profile
David Shiu
NPI 1649546458
$8,401.52
in general payments reported to CMS, 2019-2025
48 companies · $1,933 in 2025
The $1,933 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $678 · 2021: $1,250 · 2022: $1,020 · 2023: $1,409 · 2024: $1,764 · 2025: $1,933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,399 · Travel and Lodging: $429 · Education: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,399.42 |
| Travel and Lodging | $429.01 |
| Education | $277.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,625.40 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,699.26 | 2021-2025 | Breztri, Tezspire, Airsupra |
| Intuitive Surgical, INC. | $446.00 | 2023 | Da Vinci Surgical System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $387.28 | 2021-2025 | Ofev |
| Philips North America LLC | $291.40 | 2024-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Mylan Specialty L.P. | $274.00 | 2022-2024 | Yupelri |
| Grifols USA, LLC | $269.81 | 2021-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $268.79 | 2023-2025 | Opsumit, Uptravi |
| Mallinckrodt Hospital Products INC. | $238.88 | 2020-2025 | Acthar |
| Genzyme Corporation | $233.33 | 2020-2025 | |
| Amgen INC. | $184.43 | 2021-2025 | Evenity, Repatha, Otezla |
| Viatris Specialty LLC | $118.21 | 2025 | Yupelri |
| Pfizer INC. | $103.89 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $99.99 | 2025 | |
| Inspire Medical Systems, INC. | $86.86 | 2024-2025 | Inspire |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $85.24 | 2021-2023 | Wakix |
| Pulmonx Corporation | $81.80 | 2020 | |
| Insmed, INC. | $68.65 | 2020-2025 | Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $61.78 | 2021-2025 | Aralast, Glassia |
| Electromed, INC. | $57.84 | 2022-2024 | Smartvest |
| Merck Sharp & Dohme LLC | $56.70 | 2022-2024 | Capvaxive |
| Verona Pharma, INC. | $52.41 | 2025 | Ohtuvayre |
| Xeris Pharmaceuticals, INC. | $50.72 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Regeneron Healthcare Solutions, INC. | $42.98 | 2022-2024 | Dupixent |
| Sunovion Pharmaceuticals INC. | $35.81 | 2019 | |
| Alexion Pharmaceuticals, INC. | $35.69 | 2023-2025 | Strensiq |
| Vifor Pharma, INC. | $33.19 | 2025 | Zemaira |
| Ani Pharmaceuticals, INC. | $30.46 | 2024-2025 | Purified Cortrophin Gel |
| Medtronic, INC. | $29.25 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $27.71 | 2021-2022 | |
| Abbott Laboratories | $27.22 | 2021-2022 | |
| Aurinia Pharma U.S., INC. | $24.36 | 2025 | Lupkynis |
| Mallinckrodt Enterprises LLC | $23.83 | 2019 | |
| Medtronic Minimed, INC. | $22.50 | 2019 | |
| Lilly USA, LLC | $20.43 | 2025 | Zepbound |
| Kyowa Kirin, INC. | $18.92 | 2025 | |
| Janssen Biotech, INC. | $17.97 | 2024 | Tremfya |
| Novo Nordisk INC | $17.08 | 2021 | |
| Ibsa Pharma INC. | $16.74 | 2025 | Flector, Licart, Tirosint |
| United Therapeutics Corporation | $16.51 | 2024 | Tyvaso |
| Fisher & Paykel Healthcare INC | $16.49 | 2025 | Fisher & Paykel Healthcare |
| Recordati_rare_diseases_inc. | $16.35 | 2024 | Signifor Lar, Isturisa |
| Avadel Cns Pharmaceuticals, LLC | $16.02 | 2024 | Lumryz |
| Mannkind Corporation | $15.95 | 2024 | |
| Shire North American Group INC | $14.33 | 2019 | |
| Amarin Pharma, INC. | $13.96 | 2021 | |
| Genentech USA, INC. | $12.64 | 2022 | |
| Nabriva Therapeutics, Plc | $12.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.